Recognized for the delivery of diagnostic innovation, the effectiveness of the workflow and the leadership of business imagery through advanced visualization solutions
San Antonio,, July 28, 2025 / Prnewswire / – Frost & Sullivan is pleased to announce that Siemens Healthineers has received recognition from the company of the year 2025 of the North America Company in the Advanced Visualization Applications Industry for its exceptional achievements in diagnostic innovation, transparent platform integration and customer impact. This recognition underlines the leadership of the Siemens Healthineers market in the transformation of medical imaging with intelligent automation, evolutionary technology and end -to -end work flow solutions. Frost & Sullivan assesses businesses thanks to a rigorous comparative analysis process through two basic dimensions: visionary innovation and the impact of customers. Siemens Healthineers has excelled in both, demonstrating a convincing capacity to align the development of long -term products with the evolution of health systems demands while executing in a coherent manner in complex clinical environments and high issues. “By continuously translating real information on very efficient solutions, Siemens Healthineers maintains his reputation as a favorite partner in global health systems,” said Annantharaman ViswanathanResearch director at Frost & Sullivan.
Guided by a targeted growth strategy focused on organic development, digital innovation and deep customer partnerships, Siemens Healthineers shapes the future of advanced visualization (AV) by providing evolutionary integrated platforms that improve diagnostic confidence and operational agility. The sustainable investment of the company in intelligent imaging software and the adaptive integration of the workflow allowed it to lead in an increasingly defined sector by complexity, interoperability and large -scale performance.
At the heart of the AV management of Siemens Healthineers is his sygo.Via platform, which feeds multimodal applications specific to the disease for specialties such as radiology, oncology, neurology and cardiology. Transparently integrated into the backbone of business imagery, Sygo Carbon, sygo.Via offers 3D and 4D visualization, AI compatible segmentation and robust quantitative analysis – all designed to allow clinicians to make rapid and precise decisions in the care continuum. The interoperability and modularity of this ecosystem distinguish it from fragmented solutions, allowing health care providers to normalize diagnostics, rationalize the continuity of data and reduce the variability of interpretation.
Innovation extends beyond clinical tools to include the Siemens Healthineers delivery model. Unlike competitors based on external acquisitions, the company offers an entirely local ecosystem, designed for consistency, security and adaptability. Shared digital workspaces allow multi-site collaboration, ensuring that radiologists, referenced doctors and whole care teams can access and interpret the results of the imagery, whatever the place. These collaboration capacities are also supported by structured reporting tools and integrated clinical decision assistance, which help unify diagnostic standards and promote practices based on evidence.
“We are honored to receive the Prize for the company of the year of Frost & Sullivan, which reflects the commitment of our team to provide a significant innovation which stimulates a clinical impact. Our advanced visualization portfolio authorizes the treatment teams to the tools they need to make more confident and more confident decisions throughout the patient’s journey,” said Marcus da SilvaHead of the clinical and efficiency portfolio at Siemens Healthineers. “This recognition strengthens our mission to support health systems with evolutionary and intelligent solutions that allow better results without compromise.
The company’s commitment to the excellence of the implementation is just as convincing. Siemens Healthineers provides the structured integration that aligns with the infrastructure and workflow of each organization. Integrated education modules, specific training in roles and current professional development guarantee rapid adoption of users and reduce technical general costs. By aligning its technology with the functioning of clinicians, the company stimulates high use of use and a long -term system value.
Frost & Sullivan congratulates Siemens Healthineers to have increased the bar in an advanced visualization. By unifying clinical, operational and financial priorities thanks to a user -centered design philosophy, the company allows health care organizations to obtain better results for patients, without compromise.
Each year, Frost & Sullivan presents the company’s price of the year to a company that demonstrates the development and implementation of exceptional strategy, resulting in measurable improvements on the market, customer satisfaction and competitive positioning. The prize recognizes avant-garde organizations that reshape their industries by innovation and excellence of growth.
The Frost & Sullivan Best Practices prices recognize companies in various regional and global markets to demonstrate an exceptional achievement and higher leadership, technological innovation, customer service and the development of strategic products. Industry analysts compare market players and measure performance through interviews, analyzes and in -depth secondary research to identify best practices in industry.
About Frost & Sullivan
For six decades, Frost & Sullivan has been world -renowned for its role in investing aid, business leaders and governments of economic changes and the identification of disruptive technologies, mega trends, new commercial models and businesses with action, which has led to a continuous flow of growth possibilities to stimulate future success. Contact us: start the discussion.
Contact:
Ashley Shreve
E: ashley.weinkauf@frost.com
About Siemens Healthineers
Siemens Healthineers Pioneers allow health care. For everyone. Everywhere. Durably. The company is a global supplier of health equipment, solutions and services, with activities in more than 180 countries and a direct representation in more than 70. The group includes Siemens Healthineers AG, listed as SHL in Frankfurt, Germanyand its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to health care for unprecedented communities in the world and strives to overcome the most threatening diseases. The company is mainly active in the fields of imaging, diagnosis, care against cancer and mini-invasive therapies, increased by digital technology and artificial intelligence. During the 2024 fiscal year, which ended September 30, 2024Siemens Healthineers had around 72,000 employees worldwide and generated income of around 22.4 billion euros. Further information is available to: www.siemens-salthineers.com.
Contact:
Jeff Bell
E: jeffrey.t.bell@siemens-healthineers.com
Source Frost & Sullivan
